banner

Article Submission

Submit an Article

If you have an informed opinion or news on the stock market, trading or a public company (or even something about the economy) that you’d like to share with the OTCShowcase community, we’d like to publish it!  Not sure if it exactly relates?  Send it to us and we’ll decide.

Submit your article by emailing it to support[at]otcshowcase.com (you’re going to have to type it out and replace the [at] with @ or by clicking the “Submit an article” link in the footer of any page.  That link has been obfuscated to avoid spam bots).   Please include your name, website, logo and any proper disclaimer/disclosure.

We will get to your submission as expeditiously as possible, but it will be reviewed before being posted on our website.  The article must be written in English and meet our quality standards for content and grammar.  Please do your best to ensure that there aren’t any typos.  We do reserve the right to make necessary modifications to suit our readers.




Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.